Glenn J. Bubley - Concepedia

Author

Glenn J. Bubley

Beth Israel Deaconess Medical Center ORCID

Also Known As

Assunta De Rienzo, Elias Campo, Eva Giné, G Bubley, G J Bubley, G. Bubley, G. J. Bubley, G.J. Bubley, GJ Bubley, GLENN J. BUBLEY

428

Publications

55.7K

Citations

H-Index

114

Concepts

All Affiliations

Beth Israel Deaconess Medical Center Dana-Farber Cancer Institute Harvard University Brigham and Women's Hospital Memorial Sloan Kettering Cancer Center

About

Glenn J. Bubley is an author at Beth Israel Deaconess Medical Center specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	50	8K
2	Health Sciences	8	8	705
3	Engineering	2	2	912
4	Natural Sciences	2	2	338
5	Public Health	1	1	16

Glenn J. Bubley

114

Publications

20.2K

Citations

H-Index

Page 1

	Year	Citations
The Molecular Taxonomy of Primary Prostate Cancer Adam Abeshouse, Jaeil Ahn, Rehan Akbani, Cell UrologyGenitourinary CancerMedicinePathologyPrimary Prostate Cancer	2015	3.1K
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group Howard I. Scher, Susan Halabi, Ian F. Tannock, Journal of Clinical Oncology	2008	2.2K
Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate Cancer Mary‐Ellen Taplin, Glenn J. Bubley, Todd D. Shuster, New England Journal of Medicine	1995	1.3K
Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer Michael Stanbrough, Glenn J. Bubley, Kenneth N. Ross, Cancer Research	2006	1.1K
Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group Glenn J. Bubley, Michael A. Carducci, William L. Dahut, Journal of Clinical Oncology	1999	979
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines Kyle Ellrott, Matthew H. Bailey, Gordon Saksena, Cell Systems EngineeringGeneticsGenomicsArtifact FilteringTcga Data	2018	895
Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist. Mary‐Ellen Taplin, Glenn J. Bubley, Yoo‐Joung Ko, PubMed Prostate CancersAndrogen ReceptorUrologyOncologyGenitourinary Cancer	1999	599
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas Franz X. Schaub, Varsha Dhankani, Ashton C. Berger, Cell Systems	2018	434
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics Li Ding, Matthew H. Bailey, Eduard Porta‐Pardo, Cell	2018	425
Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors Changmeng Cai, Sen Chen, Patrick Kwok‐Shing Ng, Cancer Research Tumor BiologyAndrogen ReceptorUrologyEndocrine-related CancerMedicine	2011	418

Page 1